Discover
VRCA
Verrica Pharmaceuticals Inc.
4.45
2 x 3.32
2 x 5.76
bid
ask
-
0.20
4.30%
2 @ 07:30 PM
4.53 +0.08 (1.80%)
| Ytd | -46.45% | |
| 1y | 10.15% |
4.45
day range
4.67
3.28
52 week range
9.10
| Open | 4.61 | Prev Close | 4.65 | Low | 4.45 | High | 4.67 | Mkt Cap | 76.45M |
| Vol | 114.16K | Avg Vol | 63.80K | EPS | -1.74 | P/E | N/A | Forward P/E | -1.19 |
| Beta | 1.46 | Short Ratio | 3.19 | Inst. Own | 15.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 5.24 | 200-d Avg | 6.24 | 1yr Est | 6.33 |
| Income Statement | |||
| Total Revenue | 5.86M | ||
| Revenues (USD) | 5.86M | ||
| Cost of Revenue | 878.00K | ||
| Gross Profit | 4.98M | ||
| Operating Expenses | 18.08M | ||
| Research and Development Expense | 6.03M | ||
| Selling, General and Administrative Expense | 10.35M | ||
| Operating Income | -13.10M | ||
| Interest Expense | 164.00K | ||
| Net Income | -13.15M | ||
| Net Income Common Stock | -13.15M | ||
| Net Income Common Stock (USD) | -13.15M | ||
| Consolidated Income | -13.15M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -12.99M | ||
| Earning Before Interest & Taxes (USD) | -12.99M | ||
| Weighted Average Shares | 21.31M | ||
| Weighted Average Shares Diluted | 21.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.20M | ||
| Cash and Equivalents (USD) | 11.20M | ||
| Trade and Non-Trade Receivables | 11.09M | ||
| Current Assets | 32.64M | ||
| Property, Plant & Equipment Net | 2.03M | ||
| Total Assets | 36.02M | ||
| Debt Current | 956.00K | ||
| Total Debt | 1.81M | ||
| Current Liabilities | 22.44M | ||
| Debt Non-Current | 854.00K | ||
| Total Liabilities | 31.71M | ||
| Accumulated Retained Earnings (Deficit) | -347.75M | ||
| Shareholders Equity | 4.31M | ||
| Shareholders Equity (USD) | 4.31M | ||
| Assets Non-Current | 3.38M | ||
| Total Debt (USD) | 1.81M | ||
| Deferred Revenue | 1.34M | ||
| Inventory | 2.71M | ||
| Liabilities Non-Current | 9.27M | ||
| Trade and Non-Trade Payables | 1.60M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 207.00K | ||
| Net Cash Flow from Financing | -126.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.40M | ||
| Issuance (Repayment) of Debt Securities | -126.00K | ||
| Net Cash Flow from Operations | -9.28M | ||
| Share Based Compensation | 1.21M | ||